Straumann Holding AG

QS51

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: [email protected]

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    11,815

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,467.004.400.05%
CAC 407,850.10106.351.37%
DAX 4023,566.5467.220.29%
Dow JONES (US)42,410.101,160.722.81%
FTSE 1008,604.9850.180.59%
HKSE23,549.46681.722.98%
NASDAQ18,708.34779.434.35%
Nikkei 22537,644.26140.930.38%
NZX 50 Index12,676.7571.680.57%
S&P 5005,844.19184.283.26%
S&P/ASX 2008,233.502.300.03%
SSE Composite Index3,369.2427.250.82%

Market Movers